Cost-effectiveness of atosiban versus placebo for threatened preterm birth (APOSTEL 8 trial)

Larissa van der Windt, Martijn Oudijk, Job Klumper, Tobias Nijman, Judith Bosmans, Ben Willem Mol, Joris van der Post, Carolien Roos, Stavros Petrou, Kate Walker

Open source

DOI: 10.1371/journal.pone.0347475
Published: 2026-11-05
Container: PLOS One
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0347475,
  title = {Cost-effectiveness of atosiban versus placebo for threatened preterm birth (APOSTEL 8 trial)},
  author = {Larissa van der Windt and Martijn Oudijk and Job Klumper and Tobias Nijman and Judith Bosmans and Ben Willem Mol and Joris van der Post and Carolien Roos and Stavros Petrou and Kate Walker},
  year = {2026},
  journal = {PLOS One},
  doi = {10.1371/journal.pone.0347475},
  url = {https://doi.org/10.1371/journal.pone.0347475}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of atosiban versus placebo for threatened preterm birth (APOSTEL 8 trial)
AU  - Larissa van der Windt
AU  - Martijn Oudijk
AU  - Job Klumper
AU  - Tobias Nijman
AU  - Judith Bosmans
AU  - Ben Willem Mol
AU  - Joris van der Post
AU  - Carolien Roos
AU  - Stavros Petrou
AU  - Kate Walker
PY  - 2026
JO  - PLOS One
DO  - 10.1371/journal.pone.0347475
UR  - https://doi.org/10.1371/journal.pone.0347475
ER  -

APA

Windt, L. V. D., Oudijk, M., Klumper, J., Nijman, T., Bosmans, J., Mol, B. W., Post, J. V. D., Roos, C., Petrou, S., & Walker, K. (2026). Cost-effectiveness of atosiban versus placebo for threatened preterm birth (APOSTEL 8 trial). PLOS One. https://doi.org/10.1371/journal.pone.0347475

Source records

crossref · retrieved 2026-11-07T10:26:08.555Z